SAN FRANCISCO, Oct. 07, 2016 -- Hagens Berman Sobol Shapiro LLP alerts investors in Inteliquent, Inc. that the firm is investigating possible securities law violations by the Company and its officers.
If you purchased or otherwise acquired securities of Inteliquent before September 19, 2016 and suffered over $50,000 in losses contact Hagens Berman Sobol Shapiro LLP. For more information visit:
https://www.hbsslaw.com/cases/IQNT
or contact Reed Kathrein, who is leading the firm’s investigation, by calling 510-725-3000 or emailing [email protected].
During Inteliquent’s February 18, 2016 earnings conference call, the Company provided 2016 revenue guidance of $370 to $390 million. The Company reiterated its guidance during the Company’s April 28, 2016 earnings conference call. On August 2, 2016, Inteliquent missed profit expectations and reduced revenue guidance to $360 to $370 million, driving the price of the Company’s shares down over 20% to close at $16.60 that day.
On September 19, 2016, Inteliquent announced its CFO resigned. In response to this news, the price of the Company’s shares fell over 8% to close at $15.34 on September 20, 2016.
Prior to the Company’s guidance reduction and stock drop, an Inteliquent director sold nearly $5 million worth of Company stock in July 2016.
“We’re looking into when the Company and management knew they would reduce revenue guidance,” said Hagens Berman partner Reed Kathrein.
Whistleblowers: Persons with non-public information regarding Inteliquent should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new SEC whistleblower program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 510-725-3000 or email. [email protected].
About Hagens Berman
Hagens Berman is a national investor-rights law firm headquartered in Seattle, Washington with offices in 10 cities. The Firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the Firm and its successes can be found at www.hbsslaw.com. Read the Firm’s Securities Newsletter, and visit the blog. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.
Contact: Reed Kathrein, 510-725-3000


FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
OpenAI Explores Massive Funding Round at $750 Billion Valuation
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery 



